About the Event
bit.bio is a synthetic biology company providing human cells for research, drug discovery, and cell therapy. The company applies a patented, safe harbor gene-targeting approach to reprogram human induced pluripotent stem cells into highly defined and mature human cell types.
Please join us to hear from bit.bio co-founder and Chief Corporate Officer, Florian Schuster to learn how the company’s mission to turn biology into engineering will transform treatment for cancer, metabolic, and immune diseases.